Related Experiment Video
Updated: Aug 16, 2026

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
Mucormycosis in leukemia
Abstract:
Rhinocerebral mucormycosis is a virulent, rapidly progressive, potentially fatal illness which demands early diagnosis and aggressive medical and possible surgical therapy. Although most commonly reported in persons with poorly controlled diabetes, it may occur in other immunosuppressed hosts. In persons with leukemia the disease has been uniformly fatal. A well-documented case of fatal rhinocerebral mucormycosis in a leukemic patient is presented to illustrate the diagnostic and therapeutic dilemmas often faced. A review of the 233 cases thus far reported in the literature is used as a spring-board for a discussion of the pathogenesis, diagnosis, and management of this disease.
Insights
Rhinocerebral mucormycosis is a deadly fungal infection, often fatal in leukemia patients. Early diagnosis and treatment are crucial for managing this aggressive illness.
Area of Science:
- Infectious Diseases
- Mycology
- Hematology
Background:
- Rhinocerebral mucormycosis is a severe, rapidly progressing fungal infection.
- It primarily affects individuals with uncontrolled diabetes but also occurs in other immunosuppressed populations.
- Leukemia patients with this infection have historically faced a uniformly fatal outcome.
Observation:
- Presents a case of fatal rhinocerebral mucormycosis in a leukemic patient.
- Highlights the diagnostic and therapeutic challenges in managing this condition.
- Reviews 233 previously reported cases from the literature.
Findings:
- Discusses the pathogenesis, diagnosis, and management strategies for rhinocerebral mucormycosis.
- Emphasizes the aggressive nature and high mortality rate, particularly in leukemic hosts.
- Underscores the need for prompt medical and potential surgical intervention.
Implications:
- Informs clinicians about the critical need for early recognition and aggressive management of rhinocerebral mucormycosis.
- Contributes to understanding the disease's progression and outcomes in immunosuppressed patients.
- Provides a basis for further research into effective therapeutic approaches for this life-threatening infection.
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Fungal Group Zygomycota
Cryptococcal Meningitis

